Cohen Capital Management Inc. increased its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 22.4% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,150 shares of the semiconductor company's stock after acquiring an additional 2,585 shares during the quarter. Cohen Capital Management Inc.'s holdings in Synopsys were worth $6,154,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of SNPS. Salem Investment Counselors Inc. lifted its holdings in shares of Synopsys by 4.7% in the 3rd quarter. Salem Investment Counselors Inc. now owns 3,772 shares of the semiconductor company's stock worth $1,641,000 after purchasing an additional 171 shares in the last quarter. Ulland Investment Advisors LLC increased its stake in Synopsys by 4.7% during the 3rd quarter. Ulland Investment Advisors LLC now owns 2,073 shares of the semiconductor company's stock valued at $902,000 after purchasing an additional 93 shares in the last quarter. Signal Advisors Wealth LLC acquired a new position in Synopsys during the third quarter worth $303,000. B. Riley Wealth Advisors Inc. acquired a new position in Synopsys during the third quarter worth $211,000. Finally, Affinity Capital Advisors LLC raised its holdings in Synopsys by 364.7% during the third quarter. Affinity Capital Advisors LLC now owns 7,408 shares of the semiconductor company's stock worth $3,222,000 after buying an additional 5,814 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on SNPS shares. Sanford C. Bernstein initiated coverage on shares of Synopsys in a report on Friday, September 25th. They set an "outperform" rating for the company. UBS Group set a $570.00 target price on shares of Synopsys in a report on Thursday, August 27th. Needham & Company LLC raised their price target on shares of Synopsys from $580.00 to $620.00 and gave the company a "buy" rating in a research report on Monday. Rothschild & Co Redburn cut their price target on Synopsys from $560.00 to $550.00 and set a "buy" rating for the company in a research note on Wednesday, September 23rd. Finally, Benchmark reissued a "buy" rating and set a $570.00 price objective on shares of Synopsys in a report on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $571.78.
Check Out Our Latest Stock Analysis on Synopsys
Insiders Place Their Bets
In related news, CFO Sudhindra Kankanwadi sold 9,170 shares of Synopsys stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the sale, the chief financial officer directly owned 22,717 shares in the company, valued at approximately $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Aart de Geus sold 25,000 shares of the business's stock in a transaction on Monday, August 31st. The stock was sold at an average price of $441.76, for a total value of $11,044,000.00. Following the completion of the transaction, the insider directly owned 120,421 shares in the company, valued at approximately $53,197,180.96. This represents a 17.19% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 102,559 shares of company stock worth $44,607,141 over the last 90 days. 0.56% of the stock is currently owned by corporate insiders.
Synopsys Price Performance
SNPS opened at $494.51 on Wednesday. The firm's fifty day moving average price is $423.97 and its two-hundred day moving average price is $440.26. The company has a market capitalization of $94.77 billion, a price-to-earnings ratio of 87.37, a P/E/G ratio of 2.05 and a beta of 1.21. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. Synopsys, Inc. has a 1 year low of $362.55 and a 1 year high of $539.48.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts' consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. During the same period last year, the firm earned $3.39 earnings per share. The firm's revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 10.97 earnings per share for the current fiscal year.
Synopsys announced that its board has approved a share buyback program on Monday, October 5th that allows the company to buy back $1.00 billion in shares. This buyback authorization allows the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's board believes its stock is undervalued.
Synopsys Profile
(
Free Report)
Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.
The company's offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.